Digital Twin Applications in Diabetes Management: Scoping Review
Open Access
- 18 June 2026
- journal article
- review article
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 11 (1) , e83059
Abstract
Background: Digital twin (DT) systems have emerged as a promising approach in health care, enabling real-time, patient-specific virtual modeling and personalized interventions. In diabetes care, DTs offer the potential to revolutionize glucose management, decision support, and therapy personalization through integration of real-time and longitudinal patient data. Objective: This scoping review mapped the current landscape of DT applications in diabetes and synthesized evidence across 13 research questions organized into 7 thematic domains: system design, target conditions, data sources, personalization strategies, intelligence and adaptability, validation methods, and implementation considerations. Methods: This scoping review was conducted in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and JBI methodological guidance for scoping reviews. A literature search was performed in PubMed, IEEE Xplore, Scopus, and Web of Science for studies published up to April 2025; all databases were last searched on June 23, 2025. Eligible studies were original empirical articles in English that described patient-specific DT systems or closely related individualized virtual models applied to diabetes diagnosis, monitoring, management, treatment, or complication-related care. Reviews, editorials, commentaries, theoretical papers without original data, and studies not focused on diabetes were excluded. Furthermore, FSR, MJ, and KK independently screened records and assessed full texts, with disagreements resolved through discussion and, when needed, by EB. Data were charted using a structured framework based on 13 predefined research questions, and were synthesized descriptively and thematically. Results: Of 208 records identified, 123 underwent title and abstract screening, 39 full texts were assessed for eligibility, and 28 studies were included. Most studies focused on type 1 or type 2 diabetes and used data-driven, hybrid, or simulation-based DT approaches. Common clinical applications included therapeutic control, glucose prediction, decision support, and disease management. Lifestyle data, wearables, continuous glucose monitoring, and electronic health records were the dominant inputs, while personalization relied on adaptive feedback, insulin optimization, and behavior-driven tools. Intelligent features, such as adaptive learning, explainable artificial intelligence, and real-time synchronization, enhanced adaptability, although human oversight was rare. Validation was mainly retrospective or simulation-based, with few clinical trials; reported outcomes included improved hemoglobin A 1c , time-in-range, and reduced hypoglycemia. Ethical discussions focused on data privacy, while implementation barriers centered on validation gaps, data quality, and workflow integration. Conclusions: DT research in diabetes is expanding and shows strong potential for personalized and data-driven care; however, the evidence base remains heterogeneous, inconsistently reported, and limited in prospective clinical validation. Key gaps include standardized definitions, robust real-world evaluation, fairness and governance considerations, and integration into clinical workflows. Future work should prioritize clinically grounded validation, regulatory readiness, and interoperable architectures to support safe, equitable, and scalable implementation.Keywords
This publication has 37 references indexed in Scilit:
- Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort studyClinical Diabetes and Endocrinology, 2021
- Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment ProgramScientific Reports, 2021
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021Diabetes Care, 2020
- Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective AnalysisDiabetes Therapy, 2020
- Updated methodological guidance for the conduct of scoping reviewsJBI Evidence Synthesis, 2020
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAnnals of Internal Medicine, 2018
- Digital Twins in Health Care: Ethical Implications of an Emerging Engineering ParadigmFrontiers in Genetics, 2018
- In Silico Closed-Loop Control Validation Studies for Optimal Insulin Delivery in Type 1 DiabetesIEEE Transactions on Biomedical Engineering, 2015
- Personalized State-space Modeling of Glucose Dynamics for Type 1 Diabetes Using Continuously Monitored Glucose, Insulin Dose, and Meal IntakeJournal of Diabetes Science and Technology, 2014
- Standards of medical care in diabetes2005